Informed RX

Congress Considers Loosening Restrictions on Off-label Discussions

January 30, 2018

The Pharmaceutical Information Exchange Act, H.R. 2026, would ease current communication restrictions, permitting drug and medical device companies to discuss off-label information with health insurers. The bill recently passed out of Congress’ Energy and Commerce health subcommittee.

New Industry Principles Encourage Informed Prescribing

July 27, 2016

Access to comprehensive information about a medication can keep physicians informed and yield better health care decisions, argues a new set of principles from the Biotechnology Innovation Organization and the Pharmaceutical Research and Manufacturers of America. And having better-informed physicians could be good news for patients.

American Medical Association Debates Informed Prescribing

November 7, 2014

When the American Medical Association gathers this weekend in Dallas, the House of Delegates will consider a resolution with real-world implications for how much – and what sort – of information physicians can access about the medications they prescribe.